Lynozyfic Interactions
There are 440 drugs known to interact with Lynozyfic (linvoseltamab), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 57 are major, and 383 are moderate.
- View all 440 medications that may interact with Lynozyfic
- View Lynozyfic alcohol/food interactions (1)
- View Lynozyfic disease interactions (3)
Most frequently checked interactions
View interaction reports for Lynozyfic (linvoseltamab) and the medicines listed below.
- Actemra (tocilizumab)
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Alhemo (concizumab)
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- Andembry (garadacimab)
- apremilast
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blenrep (belantamab mafodotin)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
Lynozyfic alcohol/food interactions
There is 1 alcohol/food interaction with Lynozyfic (linvoseltamab).
Lynozyfic disease interactions
There are 3 disease interactions with Lynozyfic (linvoseltamab) which include:
Report options
QR code containing a link to this page
More about Lynozyfic (linvoseltamab)
- Lynozyfic consumer information
- Compare alternatives
- Dosage information
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.